FARAH HUSAIN: Open Payments
NPI 1639303308 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 60 payments from 25 companies in 2025. Trend: 2023 $1,037 · 2024 $1,608 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $313 |
| Abbott Laboratories | 5 | $150 |
| Sequel Med Tech, LLC | 2 | $134 |
| Mannkind Corporation | 5 | $93 |
| Amneal Pharmaceuticals LLC | 3 | $65 |
| Insulet Corporation | 3 | $63 |
| Lilly USA, LLC | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Corcept Therapeutics | 2 | $44 |
| Medtronic, Inc. | 2 | $42 |
Products named: Ozempic, FREESTYLE LIBRE 3, TWIIST, AFREZZA, UNITHROID, Omnipod, JARDIANCE, Korlym.
Industry payments across TX — which companies pay providers there.
